Wuhan Seqhealth Technology Co., Ltd. was established in January 2016. It is located in the Wuhan National Bio-industry Base of Optics Valley of China, in Wuhan East Lake High-tech Development Zone -- a state-level economic development zone, with an office and experimental area of 3400 m2.
The core team is composed of highly sophisticated talents graduated from the University of California, San Diego, the University of Maryland, College Park, Chinese Academy of Sciences, Zhejiang University, Wuhan University, and Huazhong University of Science and Technology. Some of them were funded by Young Thousand Talents program or 3551 Optics Valley Talent Schema. Seqhealth has more than 100 employees, 60% of whom have a graduate-level degree.
Seqhealth is devoted to the life science research of the new generation of omics technologies, focusing on the field of high-throughput sequencing technology services. Seqhealth has developed a digital label (UMI) technology platform with deduplication and error-correction abilities in high-throughput sequencing, and established epigenetic research methods covering full species and all types of tissue. Seqhealth has been credited many honors such as National High-tech Enterprise, Gazelle Enterprise, 3551 Entrepreneurial Talent Organization, and the Little Giant Enterprise of Technology. Currently, Seqhealth has applied 5 invention patents, in which 2 have been authorized, and quite a few software copyrights.